143 related articles for article (PubMed ID: 1884882)
1. Apolipoprotein levels in non-insulin-dependent diabetes mellitus with clinical macroangiopathy.
Ikeda T; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Tekeuchi T; Mashiba H
Diabete Metab; 1991; 17(3):373-8. PubMed ID: 1884882
[TBL] [Abstract][Full Text] [Related]
2. Serum sialic acid concentration and coronary heart disease in NIDDM.
Pickup JC; Mattock MB; Crook MA; Chusney GD; Burt D; Fitzgerald AP
Diabetes Care; 1995 Aug; 18(8):1100-3. PubMed ID: 7587844
[TBL] [Abstract][Full Text] [Related]
3. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein and lipid ratios in treated non-insulin dependent diabetics.
Dean JD; Owens DR; Matthews SB
Diabetes Res; 1990 Sep; 15(1):21-5. PubMed ID: 2132196
[TBL] [Abstract][Full Text] [Related]
5. HDL subparticles and coronary artery disease in NIDDM.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
[TBL] [Abstract][Full Text] [Related]
6. [Serum lipids in diabetes mellitus. Relation to equilibration and microangiopathy].
Beylot M; Garcia I; Temori SA; Orgiazzi J; Revol A; Noel G
Diabete Metab; 1983 Sep; 9(3):199-203. PubMed ID: 6653858
[TBL] [Abstract][Full Text] [Related]
7. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus.
Ukkola O; Kervinen K; Salmela PI; von Dickhoff K; Laakso M; Kesäniemi YA
Atherosclerosis; 1993 Jun; 101(1):9-15. PubMed ID: 8216506
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibility of LDL to lipid peroxidation in non-insulin-dependent diabetes mellitus with or without macroangiopathy].
Gallou G; Ruelland A; Campion L; Allannic H; Legras B; Cloarec L
Ann Biol Clin (Paris); 1994; 52(10):695-9. PubMed ID: 7747876
[TBL] [Abstract][Full Text] [Related]
10. Raised erythrocyte polyamine levels in non-insulin-dependent diabetes mellitus with great vessel disease and albuminuria.
Seghieri G; Anichini R; Ciuti M; Gironi A; Bennardini F; Franconi F
Diabetes Res Clin Pract; 1997 Jul; 37(1):15-20. PubMed ID: 9279473
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
al-Muhtaseb N; al-Yusef AR; Bajaj JS
Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
[TBL] [Abstract][Full Text] [Related]
13. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
[TBL] [Abstract][Full Text] [Related]
14. Apolipoproteins AI and B and plasma lipid values in well-treated diabetic patients from Romania.
Dabelea D; Serban V; Băcanu G; Deutsch G; Pataki C; Dan I
Rom J Intern Med; 1995; 33(3-4):249-56. PubMed ID: 8646198
[TBL] [Abstract][Full Text] [Related]
15. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study.
Frénais R; Ouguerram K; Maugeais C; Mahot P; Maugère P; Krempf M; Magot T
Diabetologia; 1997 May; 40(5):578-83. PubMed ID: 9165227
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular disease.
Knöbl P; Pietschmann P; Schnack C; Prager R; Schernthaner G
Wien Klin Wochenschr; 1994; 106(23):728-32. PubMed ID: 7856176
[TBL] [Abstract][Full Text] [Related]
17. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
[TBL] [Abstract][Full Text] [Related]
18. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
19. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
[TBL] [Abstract][Full Text] [Related]
20. Relation of abnormal composition of lipoproteins to HbA1c levels in non-insulin dependent diabetes.
Sánchez-Cabezudo M; Ródenas S; Cuesta C
Rev Esp Fisiol; 1994 Sep; 50(3):145-51. PubMed ID: 7886271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
